Responses
Regular and Young Investigator Award Abstracts
Clinical Trial Completed
626 Long-term outcomes of a randomized trial of two multipeptide melanoma vaccines (Mel39) suggests outcome differences based on participant sex
Compose a Response to This Article
Other responses
No responses have been published for this article.
